AIDS Education

AIDS Education

AIDS: is now a commonly-used term for Acquired Immunodeficiency Syndrome and also for HIV/AIDS; WHO uses the term to ΅°denote the entire health problem associate with HIV infection.΅±

American Foundation for AIDS Research (AmFAR): was co-founded in 1985 by Dr. Mathilde Krim and by Dr. Michael Gottlieb. It remains an influential advocate for HIV/AIDS research and programs.

Anal sex: Sexual intercourse when the penis is inserted in the anus. Often used as a birth control measure by young adults.

Antibiotic: A substance that kills or inhibits the growth of organisms. Once considered a magic bullet, antibiotics are now commonly used to combat disease and infection. Indications are growing that many human viruses and bacteria are becoming resistant to current antibiotics.

Antibody: Members of a class of proteins known as immunoglobins. Antibodies may tag, destroy and neutralize bacteria, viruses or other harmful toxins. Antibodies attack infected cells, making them vulnerable to attack by other elements of the immune system.

Antigen: A foreign protein that causes an immune response (the production of antibodies to fight antigens). Common examples of antigens are the bacteria and viruses that cause human disease. The antibody is formed in response to a particular antigen unique to that antigen, reacting with no other

Walking the Walk for AIDS

UNAIDS estimates that more than 37 million adults and 2 million children are infected with HIV worldwide. The AIDS epidemic has hit the hardest in sub-Saharan Africa, where 75 percent of the women ages 15 to 24 are infected.

Closer to home, 40,000 people per year in the U.S. are infected, more than half of whom are African-American women. The latter group by itself accounts for 72 percent of all new HIV diagnoses in women.

In the face of these overwhelming statistics, what can be done? Some corporations are making a difference with contributions to charities supporting the cause and helping in other ways.

For example, Roche, a pharmaceutical company that developed the HIV protease inhibitors Invirase and Viracept, has not filed any patents for its medicines – including those for HIV/AIDS – in the least-developed nations and sub-Saharan Africa. This means that these countries, which are devastated by the epidemic, can manufacture and sell cheap, generic versions of the drugs without waiting for the patents to expire.

The company also is dedicated to increasing awareness of the illnesses.

“Roche is committed to driving social responsibility programs that increase awareness and combat the HIV/AIDS epidemic at the local and international level,” said George Abercrombie, president and CEO, Hoffmann-La Roche Inc., the U.S. pharmaceuticals headquarters of Roche.

Beyond this, Roche and its employees are working more directly to address the problem through the company’s annual Global Employee AIDS Walk in observance of World AIDS Day.

Roche employees have been participating in the walk for more than two years. In December 2005, more than 11,000 employees from 85 affiliates in 42 countries walked to raise funds for AIDS organizations. The money raised through their pledges was matched by the company.

Some of the funds are distributed to local HIV/AIDS organizations. In New Jersey, for example, funds will go to the NJ AIDS Partnership. The rest goes to children in Malawi, Africa, who have been orphaned by AIDS. The money goes to buy everything from food and clean water to shelter, books and sewing machines.

HIV is spread by sexual contact with an infected person, by sharing needles or syringes with someone who is infected or – less commonly – through transfusions of infected blood. Babies of HIV-infected women may become infected before or during birth or through breast feeding.

Anabolic Steroids Help People Suffering From HIV/AIDS

You are well aware of the specter of HIV/AIDS hovering all over the world. The Joint United Nations Programme on HIV/AIDS (UNAIDS) and the World Health Organization (WHO) reports on HIV/AIDS, disclosed in January 2006, have articulated that AIDS has estimated killed more than 25 million people since it was first recognized on June 5, 1981, making it one of the most destructive epidemics in recorded history.

Certainly, AIDS is now a pandemic, with an estimated 38.6 million people living with the disease worldwide. AIDS caused an estimated 2.4–3.3 million deaths, of which more than 570,000 were children in 2005. There are over 1 million people living with HIV or AIDS in the United States.
HIV/AIDS is chronic wasting disease. The suffering from HIV/AIDS can experience chronic wasting syndrome – a significant and unintentional weight loss. Often, physicians use anabolic steroids to help the people with chronic wasting syndrome – HIV/AIDS. There are a number of benefits of anabolic steroids when they are given to the HIV/AIDS patients.

The people suffering from chronic wasting syndrome (HIV/AIDS) experience substantial loss of body weight including both muscle and fat. Anabolic steroids do the job needed to counteract the effects of wasting. One of the natural effects of anabolic steroids on the HIV/AIDS patients is promotion of their cell growth and tissues. Anabolic steroids help to increase lean body mass, increase appetite, and increase strength of the HIV/AIDS patients. Thus, if used properly, anabolic steroids can help increase the re-growth of muscle tissues, and overall increase in lean body mass.

HIV/AIDS related chronic wasting may also cause Lipodystrophy, which is not necessarily weight loss disorder, rather it is a redistribution of fat in the body. Often fat is lost from the face, arms and legs, and it gets accumulated the back of the neck and around the abdomen. It can also lead to diabetes, hypertriglyceridemia and liver problems. However, anabolic steroids do not directly help treating lipodystrophy; they do help to reduce the fatty deposits caused by lipodystrophy.

Oxandrolone is one of the anabolic steroids that have been approved by the FDA to help counteract AIDS-related chronic wasting. Currently, it may not be a mainstream treatment because studies have revealed that the most effective dosages for AIDS-related chronic wasting are higher than the FDA approved dosages, but the drug started showing great benefits to its users

Leave a Reply

Your email address will not be published. Required fields are marked *